These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Hellmich B; Schnabel A; Gross WL Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980 [TBL] [Abstract][Full Text] [Related]
3. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease. Starkebaum G Curr Opin Hematol; 1997 May; 4(3):196-9. PubMed ID: 9209836 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus. Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486 [TBL] [Abstract][Full Text] [Related]
5. Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus. Newman KA; Akhtari M Autoimmun Rev; 2011 May; 10(7):432-7. PubMed ID: 21255689 [TBL] [Abstract][Full Text] [Related]
6. Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus. Hellmich B; Csernok E; de Haas M; von dem Borne AE; Schatz H; Gross WL; Schnabel A Am J Med; 2002 Aug; 113(2):134-9. PubMed ID: 12133752 [TBL] [Abstract][Full Text] [Related]
9. Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment. Pereira J; Velloso ED; Loterio HA; Laurindo IM; Chamone DA Acta Haematol; 1994; 92(3):154-6. PubMed ID: 7871957 [TBL] [Abstract][Full Text] [Related]
10. CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Coakley G; Iqbal M; Brooks D; Panayi GS; Lanchbury JS Arthritis Rheum; 2000 Apr; 43(4):834-43. PubMed ID: 10765928 [TBL] [Abstract][Full Text] [Related]
11. Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG. Fiechtner JJ; Miller DR; Starkebaum G Arthritis Rheum; 1989 Feb; 32(2):194-201. PubMed ID: 2920054 [TBL] [Abstract][Full Text] [Related]
12. The spectrum of large granular lymphocyte leukemia and Felty's syndrome. Liu X; Loughran TP Curr Opin Hematol; 2011 Jul; 18(4):254-9. PubMed ID: 21546829 [TBL] [Abstract][Full Text] [Related]
13. Distinctive effects of G-CSF, GM-CSF and TNFalpha on neutrophil apoptosis in systemic lupus erythematosus. Armstrong DJ; Whitehead EM; Crockard AD; Bell AL Clin Exp Rheumatol; 2005; 23(2):152-8. PubMed ID: 15895883 [TBL] [Abstract][Full Text] [Related]
14. Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome. Starkebaum G; Singer JW; Arend WP Clin Exp Immunol; 1980 Feb; 39(2):307-14. PubMed ID: 7389203 [TBL] [Abstract][Full Text] [Related]
15. Resolution of the neutropenia of Felty's syndrome by longterm administration of recombinant granulocyte colony stimulating factor. Krishnaswamy G; Odem C; Chi DS; Kalbfleisch J; Baker N; Smith JK J Rheumatol; 1996 Apr; 23(4):763-5. PubMed ID: 8730142 [TBL] [Abstract][Full Text] [Related]
16. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis]. del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668 [TBL] [Abstract][Full Text] [Related]